The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biobanking Market Research Report 2023
Synopsis
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Highlights
The global Biobanking market was valued at US$ 3154.7 million in 2022 and is anticipated to reach US$ 4707.9 million by 2029, witnessing a CAGR of 6.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biobanking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking.
The Biobanking market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biobanking market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biobanking companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Segment by Type
Equipment
Consumable
Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biobanking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Highlights
The global Biobanking market was valued at US$ 3154.7 million in 2022 and is anticipated to reach US$ 4707.9 million by 2029, witnessing a CAGR of 6.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biobanking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking.
The Biobanking market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biobanking market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biobanking companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Segment by Type
Equipment
Consumable
Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biobanking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biobanking Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Equipment
1.2.3 Consumable
1.3 Market by Application
1.3.1 Global Biobanking Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Virtual Biobanks
1.3.3 Tissue Biobanks
1.3.4 Population Biobanks
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biobanking Market Perspective (2018-2029)
2.2 Biobanking Growth Trends by Region
2.2.1 Global Biobanking Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biobanking Historic Market Size by Region (2018-2023)
2.2.3 Biobanking Forecasted Market Size by Region (2024-2029)
2.3 Biobanking Market Dynamics
2.3.1 Biobanking Industry Trends
2.3.2 Biobanking Market Drivers
2.3.3 Biobanking Market Challenges
2.3.4 Biobanking Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biobanking Players by Revenue
3.1.1 Global Top Biobanking Players by Revenue (2018-2023)
3.1.2 Global Biobanking Revenue Market Share by Players (2018-2023)
3.2 Global Biobanking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biobanking Revenue
3.4 Global Biobanking Market Concentration Ratio
3.4.1 Global Biobanking Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biobanking Revenue in 2022
3.5 Biobanking Key Players Head office and Area Served
3.6 Key Players Biobanking Product Solution and Service
3.7 Date of Enter into Biobanking Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biobanking Breakdown Data by Type
4.1 Global Biobanking Historic Market Size by Type (2018-2023)
4.2 Global Biobanking Forecasted Market Size by Type (2024-2029)
5 Biobanking Breakdown Data by Application
5.1 Global Biobanking Historic Market Size by Application (2018-2023)
5.2 Global Biobanking Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biobanking Market Size (2018-2029)
6.2 North America Biobanking Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biobanking Market Size by Country (2018-2023)
6.4 North America Biobanking Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biobanking Market Size (2018-2029)
7.2 Europe Biobanking Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biobanking Market Size by Country (2018-2023)
7.4 Europe Biobanking Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biobanking Market Size (2018-2029)
8.2 Asia-Pacific Biobanking Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biobanking Market Size by Region (2018-2023)
8.4 Asia-Pacific Biobanking Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biobanking Market Size (2018-2029)
9.2 Latin America Biobanking Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biobanking Market Size by Country (2018-2023)
9.4 Latin America Biobanking Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biobanking Market Size (2018-2029)
10.2 Middle East & Africa Biobanking Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biobanking Market Size by Country (2018-2023)
10.4 Middle East & Africa Biobanking Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Biobanking Introduction
11.1.4 Thermo Fisher Revenue in Biobanking Business (2018-2023)
11.1.5 Thermo Fisher Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Biobanking Introduction
11.2.4 Beckman Coulter Revenue in Biobanking Business (2018-2023)
11.2.5 Beckman Coulter Recent Development
11.3 Panasonic
11.3.1 Panasonic Company Detail
11.3.2 Panasonic Business Overview
11.3.3 Panasonic Biobanking Introduction
11.3.4 Panasonic Revenue in Biobanking Business (2018-2023)
11.3.5 Panasonic Recent Development
11.4 SOL Group
11.4.1 SOL Group Company Detail
11.4.2 SOL Group Business Overview
11.4.3 SOL Group Biobanking Introduction
11.4.4 SOL Group Revenue in Biobanking Business (2018-2023)
11.4.5 SOL Group Recent Development
11.5 Promega
11.5.1 Promega Company Detail
11.5.2 Promega Business Overview
11.5.3 Promega Biobanking Introduction
11.5.4 Promega Revenue in Biobanking Business (2018-2023)
11.5.5 Promega Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Biobanking Introduction
11.6.4 Merck Revenue in Biobanking Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Greiner Bio One
11.7.1 Greiner Bio One Company Detail
11.7.2 Greiner Bio One Business Overview
11.7.3 Greiner Bio One Biobanking Introduction
11.7.4 Greiner Bio One Revenue in Biobanking Business (2018-2023)
11.7.5 Greiner Bio One Recent Development
11.8 Chart Industries
11.8.1 Chart Industries Company Detail
11.8.2 Chart Industries Business Overview
11.8.3 Chart Industries Biobanking Introduction
11.8.4 Chart Industries Revenue in Biobanking Business (2018-2023)
11.8.5 Chart Industries Recent Development
11.9 Brooks Life Science
11.9.1 Brooks Life Science Company Detail
11.9.2 Brooks Life Science Business Overview
11.9.3 Brooks Life Science Biobanking Introduction
11.9.4 Brooks Life Science Revenue in Biobanking Business (2018-2023)
11.9.5 Brooks Life Science Recent Development
11.10 Tecan Group
11.10.1 Tecan Group Company Detail
11.10.2 Tecan Group Business Overview
11.10.3 Tecan Group Biobanking Introduction
11.10.4 Tecan Group Revenue in Biobanking Business (2018-2023)
11.10.5 Tecan Group Recent Development
11.11 QIAGEN
11.11.1 QIAGEN Company Detail
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Biobanking Introduction
11.11.4 QIAGEN Revenue in Biobanking Business (2018-2023)
11.11.5 QIAGEN Recent Development
11.12 BD
11.12.1 BD Company Detail
11.12.2 BD Business Overview
11.12.3 BD Biobanking Introduction
11.12.4 BD Revenue in Biobanking Business (2018-2023)
11.12.5 BD Recent Development
11.13 Lifeline Scientific
11.13.1 Lifeline Scientific Company Detail
11.13.2 Lifeline Scientific Business Overview
11.13.3 Lifeline Scientific Biobanking Introduction
11.13.4 Lifeline Scientific Revenue in Biobanking Business (2018-2023)
11.13.5 Lifeline Scientific Recent Development
11.14 Hamilton
11.14.1 Hamilton Company Detail
11.14.2 Hamilton Business Overview
11.14.3 Hamilton Biobanking Introduction
11.14.4 Hamilton Revenue in Biobanking Business (2018-2023)
11.14.5 Hamilton Recent Development
11.15 So-Low
11.15.1 So-Low Company Detail
11.15.2 So-Low Business Overview
11.15.3 So-Low Biobanking Introduction
11.15.4 So-Low Revenue in Biobanking Business (2018-2023)
11.15.5 So-Low Recent Development
11.16 TTP Labtech Ltd
11.16.1 TTP Labtech Ltd Company Detail
11.16.2 TTP Labtech Ltd Business Overview
11.16.3 TTP Labtech Ltd Biobanking Introduction
11.16.4 TTP Labtech Ltd Revenue in Biobanking Business (2018-2023)
11.16.5 TTP Labtech Ltd Recent Development
11.17 Biolife Solutions
11.17.1 Biolife Solutions Company Detail
11.17.2 Biolife Solutions Business Overview
11.17.3 Biolife Solutions Biobanking Introduction
11.17.4 Biolife Solutions Revenue in Biobanking Business (2018-2023)
11.17.5 Biolife Solutions Recent Development
11.18 DNA Genotek
11.18.1 DNA Genotek Company Detail
11.18.2 DNA Genotek Business Overview
11.18.3 DNA Genotek Biobanking Introduction
11.18.4 DNA Genotek Revenue in Biobanking Business (2018-2023)
11.18.5 DNA Genotek Recent Development
11.19 Custom Biogenic Systems
11.19.1 Custom Biogenic Systems Company Detail
11.19.2 Custom Biogenic Systems Business Overview
11.19.3 Custom Biogenic Systems Biobanking Introduction
11.19.4 Custom Biogenic Systems Revenue in Biobanking Business (2018-2023)
11.19.5 Custom Biogenic Systems Recent Development
11.20 LVL Technologies
11.20.1 LVL Technologies Company Detail
11.20.2 LVL Technologies Business Overview
11.20.3 LVL Technologies Biobanking Introduction
11.20.4 LVL Technologies Revenue in Biobanking Business (2018-2023)
11.20.5 LVL Technologies Recent Development
11.21 BioRep
11.21.1 BioRep Company Detail
11.21.2 BioRep Business Overview
11.21.3 BioRep Biobanking Introduction
11.21.4 BioRep Revenue in Biobanking Business (2018-2023)
11.21.5 BioRep Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Biobanking Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Equipment
Table 3. Key Players of Consumable
Table 4. Global Biobanking Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Biobanking Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Biobanking Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Biobanking Market Share by Region (2018-2023)
Table 8. Global Biobanking Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Biobanking Market Share by Region (2024-2029)
Table 10. Biobanking Market Trends
Table 11. Biobanking Market Drivers
Table 12. Biobanking Market Challenges
Table 13. Biobanking Market Restraints
Table 14. Global Biobanking Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Biobanking Market Share by Players (2018-2023)
Table 16. Global Top Biobanking Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biobanking as of 2022)
Table 17. Ranking of Global Top Biobanking Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Biobanking Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biobanking Product Solution and Service
Table 21. Date of Enter into Biobanking Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biobanking Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Biobanking Revenue Market Share by Type (2018-2023)
Table 25. Global Biobanking Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Biobanking Revenue Market Share by Type (2024-2029)
Table 27. Global Biobanking Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Biobanking Revenue Market Share by Application (2018-2023)
Table 29. Global Biobanking Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Biobanking Revenue Market Share by Application (2024-2029)
Table 31. North America Biobanking Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Biobanking Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Biobanking Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Biobanking Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Biobanking Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Biobanking Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Biobanking Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Biobanking Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Biobanking Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Biobanking Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Biobanking Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Biobanking Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Biobanking Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Biobanking Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Biobanking Market Size by Country (2024-2029) & (US$ Million)
Table 46. Thermo Fisher Company Detail
Table 47. Thermo Fisher Business Overview
Table 48. Thermo Fisher Biobanking Product
Table 49. Thermo Fisher Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 50. Thermo Fisher Recent Development
Table 51. Beckman Coulter Company Detail
Table 52. Beckman Coulter Business Overview
Table 53. Beckman Coulter Biobanking Product
Table 54. Beckman Coulter Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 55. Beckman Coulter Recent Development
Table 56. Panasonic Company Detail
Table 57. Panasonic Business Overview
Table 58. Panasonic Biobanking Product
Table 59. Panasonic Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 60. Panasonic Recent Development
Table 61. SOL Group Company Detail
Table 62. SOL Group Business Overview
Table 63. SOL Group Biobanking Product
Table 64. SOL Group Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 65. SOL Group Recent Development
Table 66. Promega Company Detail
Table 67. Promega Business Overview
Table 68. Promega Biobanking Product
Table 69. Promega Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 70. Promega Recent Development
Table 71. Merck Company Detail
Table 72. Merck Business Overview
Table 73. Merck Biobanking Product
Table 74. Merck Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Greiner Bio One Company Detail
Table 77. Greiner Bio One Business Overview
Table 78. Greiner Bio One Biobanking Product
Table 79. Greiner Bio One Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 80. Greiner Bio One Recent Development
Table 81. Chart Industries Company Detail
Table 82. Chart Industries Business Overview
Table 83. Chart Industries Biobanking Product
Table 84. Chart Industries Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 85. Chart Industries Recent Development
Table 86. Brooks Life Science Company Detail
Table 87. Brooks Life Science Business Overview
Table 88. Brooks Life Science Biobanking Product
Table 89. Brooks Life Science Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 90. Brooks Life Science Recent Development
Table 91. Tecan Group Company Detail
Table 92. Tecan Group Business Overview
Table 93. Tecan Group Biobanking Product
Table 94. Tecan Group Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 95. Tecan Group Recent Development
Table 96. QIAGEN Company Detail
Table 97. QIAGEN Business Overview
Table 98. QIAGEN Biobanking Product
Table 99. QIAGEN Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 100. QIAGEN Recent Development
Table 101. BD Company Detail
Table 102. BD Business Overview
Table 103. BD Biobanking Product
Table 104. BD Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 105. BD Recent Development
Table 106. Lifeline Scientific Company Detail
Table 107. Lifeline Scientific Business Overview
Table 108. Lifeline Scientific Biobanking Product
Table 109. Lifeline Scientific Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 110. Lifeline Scientific Recent Development
Table 111. Hamilton Company Detail
Table 112. Hamilton Business Overview
Table 113. Hamilton Biobanking Product
Table 114. Hamilton Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 115. Hamilton Recent Development
Table 116. So-Low Company Detail
Table 117. So-Low Business Overview
Table 118. So-Low Biobanking Product
Table 119. So-Low Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 120. So-Low Recent Development
Table 121. TTP Labtech Ltd Company Detail
Table 122. TTP Labtech Ltd Business Overview
Table 123. TTP Labtech Ltd Biobanking Product
Table 124. TTP Labtech Ltd Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 125. TTP Labtech Ltd Recent Development
Table 126. Biolife Solutions Company Detail
Table 127. Biolife Solutions Business Overview
Table 128. Biolife Solutions Biobanking Product
Table 129. Biolife Solutions Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 130. Biolife Solutions Recent Development
Table 131. DNA Genotek Company Detail
Table 132. DNA Genotek Business Overview
Table 133. DNA Genotek Biobanking Product
Table 134. DNA Genotek Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 135. DNA Genotek Recent Development
Table 136. Custom Biogenic Systems Company Detail
Table 137. Custom Biogenic Systems Business Overview
Table 138. Custom Biogenic Systems Biobanking Product
Table 139. Custom Biogenic Systems Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 140. Custom Biogenic Systems Recent Development
Table 141. LVL Technologies Company Detail
Table 142. LVL Technologies Business Overview
Table 143. LVL Technologies Biobanking Product
Table 144. LVL Technologies Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 145. LVL Technologies Recent Development
Table 146. BioRep Company Detail
Table 147. BioRep Business Overview
Table 148. BioRep Biobanking Product
Table 149. BioRep Revenue in Biobanking Business (2018-2023) & (US$ Million)
Table 150. BioRep Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biobanking Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Biobanking Market Share by Type: 2022 VS 2029
Figure 3. Equipment Features
Figure 4. Consumable Features
Figure 5. Global Biobanking Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Biobanking Market Share by Application: 2022 VS 2029
Figure 7. Virtual Biobanks Case Studies
Figure 8. Tissue Biobanks Case Studies
Figure 9. Population Biobanks Case Studies
Figure 10. Biobanking Report Years Considered
Figure 11. Global Biobanking Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Biobanking Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Biobanking Market Share by Region: 2022 VS 2029
Figure 14. Global Biobanking Market Share by Players in 2022
Figure 15. Global Top Biobanking Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biobanking as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Biobanking Revenue in 2022
Figure 17. North America Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Biobanking Market Share by Country (2018-2029)
Figure 19. United States Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Biobanking Market Share by Country (2018-2029)
Figure 23. Germany Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Biobanking Market Share by Region (2018-2029)
Figure 31. China Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Biobanking Market Share by Country (2018-2029)
Figure 39. Mexico Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Biobanking Market Share by Country (2018-2029)
Figure 43. Turkey Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Biobanking Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Thermo Fisher Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 46. Beckman Coulter Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 47. Panasonic Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 48. SOL Group Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 49. Promega Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 50. Merck Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 51. Greiner Bio One Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 52. Chart Industries Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 53. Brooks Life Science Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 54. Tecan Group Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 55. QIAGEN Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 56. BD Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 57. Lifeline Scientific Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 58. Hamilton Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 59. So-Low Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 60. TTP Labtech Ltd Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 61. Biolife Solutions Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 62. DNA Genotek Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 63. Custom Biogenic Systems Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 64. LVL Technologies Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 65. BioRep Revenue Growth Rate in Biobanking Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
